← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Stellular Bio, Inc.
Watertown, MA
$5,439,435
Total funding
4
Grants
Funding over time
peak $2M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,439,435 · 4
By mechanism
R44$4,789,435 · 2
R43$600,000 · 1
SB1$50,000 · 1
Investigators at Stellular Bio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
PLT+ Characterization and IND-Enabling Studies$2,022,100
R44 · FY2020 · HL
PLT+ Characterization and IND-Enabling Studies$952,100
R44 · FY2021 · HL
Assessment of Bioreactor-Derived Human Platelet Quality, Storage Profile, Safety, and Function$729,375
R44 · FY2016 · HL
Assessment of Bioreactor-Derived Human Platelet Quality, Storage Profile, Safety, and Function$729,375
R44 · FY2017 · HL
Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease$356,485
R44 · FY2025 · EY
Platelet Bioreactor for Treatment of Radiation-Induced Thrombocytopenia$300,000
R43 · FY2018 · AI
Platelet Bioreactor for Treatment of Radiation-Induced Thrombocytopenia$300,000
R43 · FY2017 · AI
Development of an intellectual property (IP) strategy for the commercial advancement of a Direct Phase II SBIR-funded human platelet bioreactor$50,000
SB1 · FY2016 · HL